Overview

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Treatments:
Lidocaine
Criteria
Inclusion Criteria:

- Patients undergoing single-port thoracoscopic with a left double lumen bronchial
catheter

- Age ≧ 18 years old, ≦70 years old

- Temperature, white blood cells, and hemoglobin were normal before surgery

- Patient informed consent

Exclusion Criteria:

- Patients with a history of surgery within six months

- Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important
organs

- American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ

- Allergic to lidocaine

- Bradycardia (heart rate < 60 beats/min) or atrioventricular block

- Mental disorder

- Patients requiring a right double lumen bronchial catheter